to assess the lipid-regulating effects of 2 new gemfibrozil formulations , a nonblind parallel group comparison was performed using finnish industrial workers with types iia and iib primary hyperlipoproteinemia .
C0017245
gemfibrozil
C0020476
hyperlipoproteinemia